Outset Medical is looking to expand its Tablo label to include home use by sponsoring a 40-patient investigational device exemption (IDE) trial for the all-in-one dialysis device.
Read the full article » | Posted 05/09/2017
- Bring Home the Bacon Posted 02/15/2018
- A PD Solution to Protect Peritoneal Membranes Posted 01/11/2018
- The V-Wing Didn’t Make It; Perhaps the AV-Guardian Will? Posted 01/11/2018
- Print a Kidney Posted 01/11/2018
- Baxter Theranova: More Middle Molecules, Less Albumin Loss Posted 12/14/2017